Ferroptosis-Inducing Liposomes May Offer Promising Treatment for Multiple Myeloma

Strategic Insights -

Current research out of Flinders University has yielded promising results in the treatment of multiple myeloma (MM), an incurable malignancy of plasma cells. According to the study, ferroptosis, a recently characterized form of non-apoptotic programmed cell death, may hold the key to novel treatment strategies. The research demonstrated a strong correlation between the phospholipid profile of MM and diffuse large B cell lymphoma (DLBCL) cells with their sensitivity to ferroptosis. Furthermore, liposomes composed of phospholipids-polyunsaturated fatty acid (PL-PUFA) ferroptosis substrates were shown to be effective in inducing ferroptosis in MM cells.

Key Takeaways:

  • Multiple myeloma is an incurable malignancy of plasma cells that accounts for 10% of all haematological malignancies diagnosed worldwide.
  • The research demonstrated a strong correlation between the phospholipid profile of MM and DLBCL cells with their sensitivity to ferroptosis.
  • Liposomes composed of PL-PUFA ferroptosis substrates were shown to be effective in inducing ferroptosis in MM cells, particularly when combined with the GPX4 inhibitor, RSL3.
  • The novel liposomes were readily taken up by MM cells and exhibited increased cytotoxicity and lipid ROS production compared to empty liposomes or free RSL3.
  • The research suggests that strategies such as liposomal delivery of relatively deficient ferroptosis-inducing PL-PUFAs together with other targeted agents could harness ferroptosis for the personalized treatment of MM and other cancers.

Statistics:

  • 10% of all haematological malignancies diagnosed worldwide are multiple myeloma.
  • 7.1-fold to 14.5-fold lower IC value for liposomes containing RSL3 compared to free RSL3.

Sources:

  • "Novel (1S,3R)-RSL3-Encapsulated Polyunsaturated Fatty Acid Rich Liposomes Sensitise Multiple Myeloma Cells to Ferroptosis-Mediated Cell Death. International Journal of Molecular Sciences, 2025;26(14):6579.
  • NewsRx. Data on Cancer Gene Therapy Described by Researchers at Flinders University [Novel (1S,3R)-RSL3-Encapsulated Polyunsaturated Fatty Acid Rich Liposomes Sensitise Multiple Myeloma Cells to Ferroptosis-Mediated Cell Death]. Cardiovascular Week. August 11, 2025; p 15.